GENOMIC SCORE TO TARGET THERAPY WITH A FIXED DOSE COMBINATION OF HYDRALAZINE AND ISOSORBIDE DINITRATE

被引:0
|
作者
McNamara, Dennis M. [1 ]
Feldman, Arthur [1 ]
Yancy, Clyde [1 ]
Taylor, Anne [1 ]
Dries, Daniel [1 ]
Hanley-Yanez, Karen [1 ]
Halder, Indrani [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
10.1016/S0735-1097(16)31354-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1103-083
引用
收藏
页码:1353 / 1353
页数:1
相关论文
共 50 条
  • [31] G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine
    McNamara, Dennis M.
    Taylor, Anne L.
    Tam, William
    Worcel, Manuel
    Yancy, Clyde W.
    Hanley-Yanez, Karen
    Cohn, Jay N.
    Feldman, Arthur M.
    JACC-HEART FAILURE, 2014, 2 (06) : 551 - 557
  • [32] BUDGET IMPACT ANALYSIS OF FIXED-DOSE ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE IN TREATMENT OF HEART FAILURE FROM A US MEDICARE POPULATION
    Keum, J.
    Peasah, S. K.
    VALUE IN HEALTH, 2019, 22 : S125 - S125
  • [33] Fixed-dose combination of isosorbide dinitrate and hydralazine reduces heart failure hospitalizations, length of stay, and cost in African-American Heart Failure Trial (A-HeFT)
    Linde-Zwirble, WT
    Tam, SW
    Sabolinski, M
    Ghali, J
    Villagra, VG
    Winkelmayer, WC
    Angus, DC
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S149 - S149
  • [34] Fixed-dose combination of isosorbide dinitrate and hydralazine inhibits left ventricular remodeling in well-treated severe heart failure in African-Americans: A-HeFT
    Cohn, JN
    Anand, I
    Taylor, A
    Tan, SW
    CIRCULATION, 2005, 112 (17) : U704 - U704
  • [35] Fixed-dose combination of isosorbide dinitrate and hydralazine inhibits left ventricular remodeling in well-treated severe heart failure in African-Americans: A-HeFT
    Cohn, JN
    Anand, I
    Taylor, A
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : 720 - 720
  • [36] Fixed-dose combination of isosorbide dinitrate and hydralazine improves quality of life in African Americans with heart failure: Results from African-American heart failure trial
    Carson, P
    Ghali, JK
    Tam, SW
    Worcel, M
    CIRCULATION, 2005, 112 (17) : U705 - U705
  • [37] Isosorbide dinitrate and hydralazine as add-on therapy in patients admitted with advanced decompensated heart failure
    Mullens, Wilfried
    Abrahams, Zuheir
    Francis, Gary S.
    Sokos, George
    Starting, Randall C.
    Young, James B.
    Taylor, David O.
    Tang, Wilson H. W.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S91 - S91
  • [38] BNP predicts event-free survival in African American patients with moderate to severe heart failure but does not identify responders to fixed-dose combination of isosorbide dinitrate/hydralazine
    Rame, J. Eduardo
    De Marco, Teresa
    McGlothlin, Dana
    Hu, Xinge
    Dries, Daniel L.
    Worcel, Manuel
    Tam, S. William
    Cohn, Jay N.
    CIRCULATION, 2007, 116 (16) : 650 - 651
  • [39] Effect of angiotensin converting enzyme inhibitor or beta-blocker use on the benefit of fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American heart failure trial
    Ghali, Jalal K.
    Taylor, Anne L.
    Tam, S. W.
    Sabolinski, Michael L.
    Worcel, Manuel
    Cohn, Jay N.
    CIRCULATION, 2006, 114 (18) : 572 - 572
  • [40] HYDRALAZINE AND ISOSORBIDE DINITRATE - COMPARATIVE CENTRAL AND REGIONAL HEMODYNAMIC-EFFECTS WHEN ADMINISTERED ALONE OR IN COMBINATION
    LEIER, CV
    MAGORIEN, RD
    DESCH, CE
    THOMPSON, MJ
    UNVERFERTH, DV
    CIRCULATION, 1981, 63 (01) : 102 - 109